Intracoronary thrombi are commonly found in patients with acute coronary syndromes. A large thrombus burden or a platelet-rich thrombus frequently resists pharmacologic therapy ("throm bolytic ceiling"). In such cases restoration of adequate antegrade coronary flow necessitates application of a mechanical force. Power thrombectomy is a revascularization strategy incor porating a mechanical device for removal of occlusive coronary thrombi in conjunction with or following administration of either platelet glycoprotein IIb/IIIa receptor inhibitors or thrombolytic agents, or both. Mechanical devices for power thrombectomy include ultrasound sonication, rheolytic thrombectomy (Angiojet), laser, transluminal extraction catheter, aspiration catheter, and to a limited extent, balloon angioplasty. In acute coronary syndromes the strategy of power thrombectomy aims to achieve the clinical advantages of more nearly complete vessel patency, improved antegrade flow, and enhanced preservation of myocardial tissue.
Get full access to this article
View all access options for this article.
References
1.
Lefkovitz J., Topol EJ: Platelet inhibitor agents in ischemic heart disease. Update chapter #6 In: Textbook of Cardiovascular Medicine. Cedar Knolls, NJ: Lipincott Raven, 1998, pp 1-16.
2.
Simes RJ, Topol EJ, Holmes DR, et al, for the GUSTO-1 Investigators: Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: Importance of early and complete infarct artery reperfusionCirculation91:1923-1928, 1995.
3.
GUSTO Angiographic Investigators: The effects of tissue plasminogen activator, streptokinase, or both, on coronary patency, ventricular function, and survival after acute myocardial infarctionN Engl J Med329:1615-1622, 1993 .
4.
Fibrinolytic Therapy Trialists' (FTT) Collaborative Group: Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results of all randomized trials of more than 1,000 patientsLancet343:311-322, 1994.
5.
Anderson JL, Karagounis LA, Califf RA: Meta-analysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarctionAm J Cardiol78:1-8, 1996.
6.
Cannon CP: Overcoming thrombolytic resistanceJ Am Coll Cardiol34:1395-1402, 1999.
7.
Bode C., Smalling RW, Berg G., et al, for the RAPID II Investigators: Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase and front-loaded, accelerated alteplase in patients with acute myocardial infarctionCirculation94:891-898, 1996.
8.
Cannon CP, McCabe CH, Gibson M., et al: TNK-Tissue plasminogen activator in acute myocardial infarctionCirculation95:351-356, 1997.
9.
Greilich PE, Carr ME, Zekert SL, et al: Quantitative assessment of platelet function and clot structure in patients with severe coronary artery diseaseAm J Med Sci307:15-20, 1994.
10.
Anderson JL : Why does thrombolysis fail? Breaking through the reperfusion ceilingAm J Cardiol80: 1588-1590, 1997.
11.
Carr ME, Hermans J.: Site and density of very long fibers from turbidity-application of fibrin gelsMacromolecules11:46-50, 1978.
12.
Gabriel DA, Muga K., Boothroyd EM: The effect of fibrin structure on fibrinolysisJ Biol Chem267:259-263, 1992.
13.
Cannon CP, McCabe H., Diver DJ, et al: Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 4 trialJ Am Coll Cardiol24:1602-1610, 1994 .
14.
Verheugt Fwa , Meijer A., Lagrand W., et al: Reocclusion : The flip side of coronary thrombolysisJ Am Coll Cardiol27:766-773, 1996.
15.
Ohman EM, Califf M., Topol EJ, et al: Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarctionCirculation82:781-791, 1990.
16.
Brouwer MA, Bohncke JR, Veen G., et al: Adverse long-term effects of reocclusion after coronary thrombolysisJ Am Coll Cardiol26:1440-1444, 1995 .
17.
The EPIC Investigators: Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplastyN Engl J Med330:956-961, 1994.
18.
The EPILOG Investigators: Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularizationN Engl J Med336:1689-1696, 1997 .
19.
The EPISTENT Investigators: Randomized placebo-controlled and balloon angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockadeLancet352:87-92, 1998.
20.
The IMPACT-II Investigators: Randomized placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-IILancet349:1422-1428, 1997.
21.
The CAPTURE Investigators: Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE StudyLancet349:1429-1435, 1997.
22.
The RESTORE Investigators: Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplastyCirculation96:1445-1453, 1997 .
23.
The PURSUIT Trial Investigators: Inhibition of platelet glycoprotein IIb/IIIa with eptifibative in patients with acute coronary syndromesN Engl J Med339:436-443, 1998.
24.
The SPEED Investigators: Trial of abciximab with and without low-dose retephase for acute myocardial infarctionCirculation101:278-2794, 2000.
25.
Lincoff MA, Califf RM, Moliterno DJ, et al : Complementary clinical benefits of coronary artery stenting and blockade of platelet glycoprotein IIb/IIIa receptorsN Engl J Med341:319-327, 1999.
26.
Califf RM, Lincoff AM, Tcheng JE, et al: An overview of the results of the EPIC trialEur Heart J16:43-49, 1995.
27.
Silva JA: Editorial. Percutaneous coronary intervention of thrombotic lesions: Still challenging! CathetCardiovasc Intervent56:8-9, 2002.
28.
Singh M., Reeder GS, Ohman EM, et al: Does the presence of thrombus seen on a coronary angiogram affect the outcome after percutaneous coronary angioplasty ? An angiographic trials pool data experienceJ Am Coll Cardiol38:624-630, 2001.
29.
Zhao XQ, Theroux P., Snappin SM, et al: Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction: Angiographic results from the PRISM-PLUS trialCirculation100:1609-1615, 1999.
30.
Cura FA, L'Allier PL, Kapadia SR, et al: Predictors of TIMI ≤ 3 coronary flow after primary angioplasty in patients with acute myocardial infarctionJ Am Coll Cardiol35:20A, 2000.
31.
Grines CL, Browne KF, Marco J., et al: A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarctionN Engl J Med328: 673-679, 1993.
32.
GUSTO-IIb Angioplasty Substudy Investigators : A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarctionN Engl J Med336:1621-1628, 1997 .
33.
Zijlstra F. : Primary angioplasty is the most effective treatment for an acute myocardial infarctionBr Heart J73:403-404, 1995.
34.
White CJ, Ramee SR, Collins TJ, et al: Coronary thrombi increase PTCA riskCirculation93:253-258, 1996.
35.
Saber RS, Edwards WD, Bailey KR, et al: Coronary embolization after balloon angioplasty or thrombolytic therapy: An autopsy study of 32 casesJ Am Coll Cardiol22:1283-1288, 1993.
36.
Rashdan I., Schechter E.: Safety and efficacy in abciximab use in conjunction with intracoronary urokinase in patients requiring angioplastyCathet Cardiovasc Intervent49:113-116, 2000.
37.
Siegel RJ, Steffen W., Cumberland DC: Ultrasound angioplasty In: Textbook of Interventional Cardiology , ed. by Topol EJ. Philadelphia: WB Saunders, 1958, pp 635-649.
38.
Rosenschein U., Frimerman A., Laniado S., et al: Study of the mechanism of ultrasound angioplasty from human thrombi and bovine aortaAm J Cardiol24:1263-1266, 1994.
39.
Rosenschein U., Rozenszajn LA, Kraus L., et al: Ultrasonic angioplasty in totally occluded peripheral arteries : Initial clinical, histopathologic and angiographic resultsCirculation83:1976-1986, 1991 .
40.
Rosenschein U., Gaul G., Erbel R., et al: Percutaneous transluminal therapy of occluded saphenous vein graftsCirculation99:26-29, 1999.
41.
Rosenchein U., Roth A., Rassin T., et al: Analysis of coronary ultrasound thrombolysis: End points in acute myocardial infarction (ACUTE trial)Circulation95:1411-1416, 1997.
42.
Rosenschein U., Furman V., Kerner E., et al: Ultrasound imaging-guided noninvasive ultrasound thrombolysisCirculation102:238-245, 2000.
43.
Topaz O.: Laser In: Textbook of Interventional Cardiology, ed. 4, ed. by Topol EJ. Philadelphia: WB Saunders, 2002, pp 675-703.
44.
Bittl JA, Brinker JA, Sanborn TA, et al: The changing profile of patient selection, procedural techniques and outcomes in excimer laser coronary angioplastyJ Intervent Cardiol8:654-660, 1995.
45.
Topaz O., McIvor M., Stone GW, et al: Acute results, complications and effect of lesion characteristics on outcome with solid-state, pulsed-wave, mid-infrared laser angioplasty system: Final multicenter reportLaser Surg Med22:228-239, 1998.
46.
Biamino GC, Ragg JC, Struk B., et al: Long occlusions of the superficial femoral artery: Success rate and 1year follow-up after excimer laser-assisted angioplastyEur Heart J15:(suppl 1):147, 1994.
47.
Topaz O., Morris C., Minisi AJ, et al: Enhancement of t-PA-induced fibrinolysis with laser energy: In-vitro observationsLaser Med Sci14:123-128, 1999.
48.
Topaz O., Rozenbaum EA, Schumacker A., et al : Solid-state, mid-infrared laser-facilitated coronary angioplasty : Clinical and quantitative angiographic results in 112 patientsLaser Surg Med19:260-272, 1996.
49.
Topaz O., Bernardo NL, McQueen RA, et al: Effectiveness of excimer laser coronary angioplasty in acute myocardial infarction or in unstable angina pectorisAm J Cardiol87:849-855, 2001.
50.
Topaz O., Shah R., Mohanty PK, et al: Application of excimer laser angioplasty in acute myocardial infarctionLasers Surg Med29:185-192, 2001.
51.
Dahm JB, Topaz O., Woenckhaus C., et al : Laser-facilitated thrombectomy: A new therapeutic option for treatment of thrombus-laden coronary lesionsCathet Cardiovasc Intervent56:365-372, 2002.
52.
Topaz O., Minisi AJ, Luxenberg MG, et al : Laser angioplasty for lesions unsuitable for PTCA in acute myocardial infarction: Quantitative coronary angiography and clinical resultsCirculation90(suppl I): 1-434, 1994.
Safian RD: Coronary atherectomy: Directional and extraction techniques In: Textbook of Interventional Cardiology, ed. 3, ed. by Topol EJ. Philadelphia: WB Saunders, 1998 , pp 501-522.
58.
Topaz O., Bernardo N., Desai P., et al: Acute thrombotic-ischemic syndromes: The usefulness of TECCathet Cardiovasc Intervent48:406-420, 1999.
59.
Sullebarger JT, Dalton RD, Nasser A., et al: Adjunct abciximab improves outcomes during recanalization of totally occluded saphenous vein grafts using TECCathet Cardiovasc Intervent46:107-110, 1999.
60.
Kim RH, Fischman DL, Dempsey CM, et al: Rheolytic thrombectomy of chronic coronary occlusionCathet Cardiovasc Diagn43:483-489, 1998.
61.
Scott Lrp, Silva JA, White C., et al: Rheolytic thrombectomy: A new treatment for stent thrombosisCathet Cardiovasc Intervent47:97-101, 1999.
62.
Nakagawa Y. , Matsuo S., Yukoi H., et al: Stenting after thrombectomy with the Angiojet catheter for acute myocardial infarctionCathet Cardiovasc Diagn43:327-330, 1998.
63.
Singh M., Tiede DJ, Mathew V., et al: Rheolytic thrombectomy with Angiojet in thrombus-containing lesionsCathet Cardiovasc Intervent56:1-7, 2002.
64.
Dohad S., Parris TM, Setum C., et al: Angiojet rheolytic thrombectomy: An important tool for percutaneous coronary interventions in high-risk patients: VeGAS II trialJ Am Coll Cardiol35(suppl A):75A, 2000.
65.
Nishida T., Nakamura M., Tsunda T., et al: A case of acute myocardial infarction treated with a new thrombectomy systemCathet Cardiovasc Intervent55:239-243, 2002.
66.
Kwok OH, Prpic R., Gaspar J., et al: Angiographic outcome after intracoronary X-Sizer helical atherectomy and thrombectomy: First use in humansCathet Cardiovasc Intervent55:133-139, 2002.
67.
Ischinger T. : Thrombectomy with the X-Sizer catheter system in the coronary circulation: Initial results from a multi-center studyJ Invas Cardiol13:81-88, 2001.
68.
Sanmartin M. , Goicolea J., Salmeron-Ruiz R., et al: Coronary perforation as a potential complication derived from coronary thrombectomy with the X-Sizer deviceCathet Cardiovasc Intervent56:378-382, 2002.
